{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:04:31Z","timestamp":1791263071990,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MENRT"},{"name":"CANAM"},{"name":"CEA","award":["P\/NRBC n\u00b013"],"award-info":[{"award-number":["P\/NRBC n\u00b013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.vaccine.2012.10.071","type":"journal-article","created":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T13:08:56Z","timestamp":1351775336000},"page":"171-175","source":"Crossref","is-referenced-by-count":17,"title":["Cell-wall preparation containing poly-\u03b3-d-glutamate covalently linked to peptidoglycan, a straightforward extractable molecule, protects mice against experimental anthrax infection"],"prefix":"10.1016","volume":"31","author":[{"given":"Thomas","family":"Candela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Dumetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Tosi-Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Mock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre L.","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Fouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.10.071_bib0005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu Rev Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.10.071_bib0010","first-page":"129","article-title":"Vaccines: countering anthrax: vaccines and immunoglobulins","volume":"46","author":"Grabenstein","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.10.071_bib0015","first-page":"335","article-title":"Anthrax: clinical features, pathogenesis, and potential biological warfare threat","volume":"20","author":"Friedlander","year":"2000","journal-title":"Curr Clin Top Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.10.071_bib0020","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1128\/IAI.06061-11","article-title":"Updating perspectives on the initiation of Bacillus anthracis growth and dissemination through its host","volume":"80","author":"Weiner","year":"2012","journal-title":"Infect Immun"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2012.10.071_bib0025","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1365-2958.1997.2941659.x","article-title":"Molecular characterization of the Bacillus anthracis main S-layer component: evidence that it is the major cell-associated antigen","volume":"23","author":"Mesnage","year":"1997","journal-title":"Mol Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.10.071_bib0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/AAC.00706-06","article-title":"Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis","volume":"51","author":"Scorpio","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"June (5)","key":"10.1016\/j.vaccine.2012.10.071_bib0035","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2958.2006.05179.x","article-title":"Poly-gamma-glutamate in bacteria","volume":"60","author":"Candela","year":"2006","journal-title":"Mol Microbiol"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2012.10.071_bib0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.resmic.2010.09.006","article-title":"AtxA, a Bacillus anthracis global virulence regulator","volume":"161","author":"Fouet","year":"2010","journal-title":"Res Microbiol"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2012.10.071_bib0045","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2958.2005.04718.x","article-title":"Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan","volume":"57","author":"Candela","year":"2005","journal-title":"Mol Microbiol"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2012.10.071_bib0050","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1128\/JB.187.22.7765-7772.2005","article-title":"CapE, a 47-amino-acid peptide, is necessary for Bacillus anthracis polyglutamate capsule synthesis","volume":"187","author":"Candela","year":"2005","journal-title":"J Bacteriol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.10.071_bib0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2958.2008.06533.x","article-title":"Capsule anchoring in Bacillus anthracis occurs by a transpeptidation reaction that is inhibited by capsidin","volume":"71","author":"Richter","year":"2009","journal-title":"Mol Microbiol"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2012.10.071_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mib.2003.12.001","article-title":"The roles of anthrax toxin in pathogenesis","volume":"7","author":"Moayeri","year":"2004","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2012.10.071_bib0065","first-page":"41","article-title":"Avirulent anthrax vaccine","volume":"21","author":"Sterne","year":"1937","journal-title":"Onderstepoort J Vet Sci Animal Ind"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.10.071_bib0070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mam.2009.07.005","article-title":"Animal models of human anthrax: the quest for the holy grail","volume":"30","author":"Goossens","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.vaccine.2012.10.071_bib0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00189414","article-title":"Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"177","author":"Turnbull","year":"1988","journal-title":"Med Microbiol Immunol"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2012.10.071_bib0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0882-4010(88)90015-0","article-title":"Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice","volume":"5","author":"Welkos","year":"1988","journal-title":"Microb Pathog"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.10.071_bib0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/mpat.1993.1037","article-title":"Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulence","volume":"14","author":"Welkos","year":"1993","journal-title":"Microb Pathog"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.10.071_bib0090","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","article-title":"Anthrax spores make an essential contribution to vaccine efficacy","volume":"70","author":"Brossier","year":"2002","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.10.071_bib0095","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1128\/IAI.01217-08","article-title":"Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax","volume":"77","author":"Gauthier","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.10.071_bib0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj0630437","article-title":"Polyglutamic acid from Bacillus anthracis grown in vivo: structure and aggressin activity","volume":"63","author":"Zwartouw","year":"1956","journal-title":"Biochem. J."},{"issue":"May (23)","key":"10.1016\/j.vaccine.2012.10.071_bib0105","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.vaccine.2012.03.023","article-title":"Sortase-conjugation generates a capsule vaccine that protects guinea pigs against Bacillus anthracis","volume":"30","author":"Garufi","year":"2012","journal-title":"Vaccine"},{"issue":"November (Suppl. 4)","key":"10.1016\/j.vaccine.2012.10.071_bib0110","doi-asserted-by":"crossref","first-page":"D28","DOI":"10.1016\/j.vaccine.2009.08.102","article-title":"Advances in the development of next-generation anthrax vaccines","volume":"27","author":"Friedlander","year":"2009","journal-title":"Vaccine"},{"issue":"December (3))","key":"10.1016\/j.vaccine.2012.10.071_bib0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/187220811797579097","article-title":"Recent progress in the development of anthrax vaccines","volume":"5","author":"Kaur","year":"2011","journal-title":"Recent Pat. Biotechnol."},{"issue":"July (1)","key":"10.1016\/j.vaccine.2012.10.071_bib0120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4049\/jimmunol.173.1.521","article-title":"High bactericidal efficiency of type IIA phospholipase A(2) against Bacillus anthracis and inhibition of its secretion by the lethal toxin","volume":"173","author":"Gimenez","year":"2004","journal-title":"J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.10.071_bib0125","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/IAI.68.4.1781-1786.2000","article-title":"Role of toxin functional domains in anthrax pathogenesis","volume":"68","author":"Brossier","year":"2000","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.10.071_bib0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/IAI.39.1.483-486.1983","article-title":"Elaboration of Bacillus anthracis antigens in a new, defined culture medium","volume":"39","author":"Ristroph","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.10.071_bib0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj0400297","article-title":"The capsular susbtance of Bacillus anthracis","volume":"40","author":"Hanby","year":"1946","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2012.10.071_bib0140","first-page":"86","article-title":"Ueber ein spezifisches Protein der Kapsel des Milzbrandbazillus","volume":"78","author":"Tomcsik","year":"1933","journal-title":"Zeitschr Immunit\u00e4t-Forsch"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.10.071_bib0145","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1128\/IAI.72.9.5460-5463.2004","article-title":"The capsule of Bacillus anthracis behaves as a thymus-independent type 2 antigen","volume":"72","author":"Wang","year":"2004","journal-title":"Infect Immun"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.10.071_bib0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4269\/ajtmh.1988.39.575","article-title":"Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand","volume":"39","author":"Sirisanthana","year":"1988","journal-title":"Am J Trop Med Hyg"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2012.10.071_bib0155","first-page":"257","article-title":"Isolation and purification of cell wall polysaccharide of Bacillus anthracis (delta sterne)","volume":"66","author":"Ekwunife","year":"1991","journal-title":"FEMS Microbiol Lett"},{"issue":"12","key":"10.1016\/j.vaccine.2012.10.071_bib0160","doi-asserted-by":"crossref","first-page":"e28377","DOI":"10.1371\/journal.pone.0028377","article-title":"The Staphylococcus aureus peptidoglycan protects mice against the pathogen and eradicates experimentally induced infection","volume":"6","author":"Capparelli","year":"2011","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.071_bib0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1179\/096805106X89044","article-title":"MDP and other muropeptides \u2013 direct and synergistic effects on the immune system","volume":"12","author":"Traub","year":"2006","journal-title":"J Endotoxin Res"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2012.10.071_bib0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2004.05.029","article-title":"Anthrax capsule vaccine protects against experimental infection","volume":"23","author":"Chabot","year":"2004","journal-title":"Vaccine"},{"issue":"Jul (15)","key":"10.1016\/j.vaccine.2012.10.071_bib0175","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1073\/pnas.1633512100","article-title":"Poly(gamma-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine","volume":"100","author":"Schneerson","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2012.10.071_bib0180","doi-asserted-by":"crossref","first-page":"e27411","DOI":"10.1371\/journal.pone.0027411","article-title":"Characterization of the sortase repertoire in Bacillus anthracis","volume":"6","author":"Aucher","year":"2011","journal-title":"PloS One"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2012.10.071_bib0185","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1128\/JB.187.19.6742-6749.2005","article-title":"Identification of the Bacillus anthracis (gamma) phage receptor","volume":"187","author":"Davison","year":"2005","journal-title":"J Bacteriol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T10:39:43Z","timestamp":1594809583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12015319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0264410X12015319"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}